The Role Brazil has played in changing global AIDS policy and promoting widespread access to AIDS treatment is explored in a new paper by academics from Scotland and the United States.
Brazil’s large-scale, successful HIV/AIDS treatment program is considered a model for other developing countries aiming to improve access to AIDS treatment.
But far less is known about the country’s important role in changing global norms related to international pharmaceutical policy, particularly international human rights, health and trade policies governing access to essential medicines.
Prompted by Brazil’s interest in preserving its national AIDS treatment policies during World Trade Organisation (WTO) trade disputes with the US, these efforts to change global essential medicines norms have had important implications for other countries, particularly those aiming to increase the AIDS treatment they provide.
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!